Silodosin as a Medical Expulsive Therapy for Distal Ureteral Stones in the Pakistani Population

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060517

Enrollment

Unknown

Registered

2022-06-04

Start date

2021-05-16

Completion date

Unknown

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteric Stones

Interventions

Case series:Silodosin

Eligibility

Sex/Gender

All

Age

19 Years to 76 Years

Inclusion criteria

Inclusion criteria: All the patients regardless of gender coming to urology outpatient department of KRL hospital with distal ureteric stone of 10mm as confirmed by ultrasonography kidney ureter bladder were included in our study.

Exclusion criteria

Exclusion criteria: Patients previously taking any medication or any other invasive procedure were excluded from our study. Patients with pyelonephritis, fever, Interactable pain or having creatinine deranged were also excluded from our study.

Design outcomes

Primary

Measure	Time frame
Stone Free Rate;	—

Countries

Pakistan

Contacts

Public ContactDR Kashif Bangash

KRL Hospital

hassanmumtaz.dr@gmail.com+92 320 9559191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026